ストーブリ Official site

Case Study: Pharmaceuticals - Aseptic Environment: Robot Automation in Vaccine Manufacturing

We will introduce a case of utilizing robots in a large-scale vaccine manufacturing facility in China.

This case is a groundbreaking success story using Stäubli's 'TX200 Stericlean' in the biopharmaceutical industry in China. Stäubli China anticipates that other companies will also advance similar automation. Currently, there are 48 vaccine manufacturing companies in China, and more than half of them have adopted processes using cell factories that require the transport and vibration of trays for vaccine production. Please take a look at practical examples of robot utilization, such as the company's transport automation. 【Benefits of Vaccine Manufacturing Automation】 ■ Automated cell production reduces investment costs and production costs ■ The number of CO2 incubators is reduced with the installation of robots ■ Reduces consumables like staff protective clothing and energy consumption for temperature control ■ Operators do not need to enter the room where vaccines are manufactured ■ The risk of contamination is minimized *For more details, please refer to the PDF document or feel free to contact us.

Related Link - https://www.staubli.com/ja-jp/

basic information

For more details, please refer to the PDF document or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.

Robot Implementation Case Study: Pharmaceuticals - Aseptic Environment: Robot Automation in Vaccine Production

TECHNICAL

News about this product(1)

Recommended products

Distributors